
Study Period | 2021 - 2030 |
Market Size (2025) | USD 9.06 Billion |
Market Size (2030) | USD 11.51 Billion |
CAGR (2025 - 2030) | 4.89 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | Low |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Acne Therapeutics Market Analysis
The Acne Therapeutics Market size is estimated at USD 9.06 billion in 2025, and is expected to reach USD 11.51 billion by 2030, at a CAGR of 4.89% during the forecast period (2025-2030).
The acne therapeutics market continues to evolve rapidly, driven by changing demographic patterns and increasing awareness of skin health among consumers globally. Recent studies highlight the significant burden of acne across different populations, with data from the United Kingdom showing that 34% of adults have suffered from acne at some point in their lives, with current prevalence rates showing interesting gender disparities—6.1% among men compared to 2.5% among women as of 2022. This demographic shift has prompted pharmaceutical companies to develop more targeted solutions for specific population segments, leading to increased investment in research and development of personalized treatment options.
The industry is witnessing a significant transformation through technological advancement and innovation in treatment modalities. Pharmaceutical companies are increasingly focusing on developing novel drug delivery systems and more effective therapeutic combinations. The emergence of new retinoid molecules represents a significant breakthrough in acne treatment, with companies like Galderma leading the way in developing next-generation solutions. These innovations are particularly focused on reducing side effects while improving efficacy, addressing a long-standing challenge in the acne therapeutics market.
Strategic partnerships and consolidation activities are reshaping the competitive landscape of the global acne therapeutics market. Major pharmaceutical companies are actively pursuing collaborations with biotechnology firms and research institutions to enhance their product portfolios and expand their market presence. This trend is particularly evident in the development of combination therapies and novel drug delivery systems, which are becoming increasingly important in addressing the complex nature of acne treatment. Companies are also investing in digital health solutions and telemedicine platforms to improve treatment accessibility and patient compliance.
Consumer education and treatment accessibility have become central focus areas for industry stakeholders. Pharmaceutical companies are launching comprehensive awareness campaigns and educational initiatives to improve understanding of acne treatments and their proper usage. For instance, Galderma's launch of the "Me Being Me" digital campaign represents a significant shift towards more patient-centric marketing approaches. These initiatives are complemented by the increasing adoption of telemedicine and digital health platforms, which are making professional dermatological care more accessible to broader population segments, particularly in underserved areas. The acne vulgaris market is also seeing growth as these efforts expand.
Acne Therapeutics Market Trends
Rising Healthcare Costs
The increasing healthcare expenditure across major markets has significantly impacted the acne treatment market trends, driving innovations in treatment options and delivery methods. In the United States, the growing out-of-pocket expenses for dermatological treatments have led to the development of more cost-effective solutions, including over-the-counter medications and generic alternatives. The emergence of prescription-strength retinoids available without a prescription, such as Stryke Club's Knockout Adapalene Gel launched in 2022, demonstrates the industry's response to making effective treatments more accessible and affordable for patients.
The healthcare cost burden has also prompted insurance providers and healthcare systems to focus on preventive care and early intervention strategies for acne management. This shift has resulted in increased investment in patient education programs and the development of comprehensive treatment protocols that combine multiple therapeutic approaches. The integration of cost-effective combination therapies, such as the three-compound combination gel IDP-126, showcases the industry's effort to provide efficient and economical treatment options while maintaining therapeutic efficacy.
Technological Innovations
The acne drugs market has witnessed substantial technological advancements, particularly in the development of novel drug delivery systems and combination therapies. The introduction of innovative formulations, such as Bausch Health's IDP-126 combining adapalene, retinol, and antimicrobial benzoyl peroxide, represents a significant breakthrough in treating both inflammatory and non-inflammatory lesions. These technological innovations have enhanced treatment efficacy while minimizing side effects, leading to improved patient compliance and better therapeutic outcomes.
The integration of advanced molecular stabilizing technologies and sophisticated delivery mechanisms has revolutionized topical treatments for acne. For instance, the development of Molecule Stabilizing Technology (MST) Franchise products and the introduction of novel retinoid molecules demonstrate the industry's commitment to technological advancement. The approval of new treatments like AviClear by Cutera in 2022 for treating mild, moderate, and severe acne showcases the continuous evolution of therapeutic technologies, providing more targeted and effective treatment options for patients with various degrees of acne severity.
Increasing Remote Patient Monitoring
The dermatology sector has experienced a significant transformation with the integration of remote monitoring capabilities and teledermatology services. Healthcare providers have increasingly adopted digital platforms and mobile applications for patient monitoring and treatment adherence tracking. The launch of innovative solutions like the Clear90 app by Differin demonstrates the industry's commitment to leveraging technology for patient education and treatment monitoring, enabling healthcare providers to track progress and adjust treatment plans remotely.
The advancement in remote monitoring technologies has facilitated more personalized treatment approaches and improved patient engagement in acne management. Digital platforms now enable dermatologists to conduct virtual consultations, monitor treatment progress through photo documentation, and provide real-time adjustments to treatment protocols. This technological integration has particularly benefited patients in underserved areas, improving access to specialized dermatological care while maintaining treatment quality and consistency.
Growing Burden of Chronic Diseases
The increasing prevalence of chronic skin conditions, particularly acne vulgaris, has become a significant healthcare concern affecting both adolescent and adult populations. According to recent statistics from the Canadian Skin Patient Alliance (CSPA) in September 2022, 37% of respondents reported having mild acne, while 47% experienced moderate acne, and 16% suffered from severe acne, highlighting the substantial burden of this chronic condition. The persistent nature of acne and its impact on patients' quality of life has driven the demand for more effective and long-term therapeutic solutions.
The chronic disease burden is further complicated by the psychological and social implications of acne, necessitating comprehensive treatment approaches. The development of novel therapeutic options, such as Winlevi (Clascoterone cream 1%), the first-in-class topical therapy for acne vulgaris, demonstrates the industry's response to addressing the growing chronic disease burden. The expansion of treatment options and continued research into new therapeutic approaches reflects the healthcare system's commitment to managing the increasing prevalence of chronic skin conditions effectively. The anti-acne treatment market continues to expand as new solutions are developed to address these challenges.
Segment Analysis: By Treatment
Therapeutics Segment in Acne Therapeutics Market
The therapeutics segment dominates the global acne treatment market by treatment, commanding approximately 80% of the total market share in 2024. This segment encompasses various treatment options, including retinoids, antibiotics, hormonal agents, anti-inflammatory medications, and other therapeutic agents. The substantial market share can be attributed to the increasing prevalence of acne vulgaris globally and the growing adoption of prescription medications for treating moderate to severe acne cases. The segment's dominance is further strengthened by continuous product innovations, particularly in topical combination therapies, and the expanding availability of both generic and branded therapeutic options across different regions. Additionally, the rising awareness about advanced acne treatments and improving healthcare infrastructure in emerging economies has contributed significantly to the segment's market leadership.

Other Treatments Segment in Acne Therapeutics Market
The other treatments segment, which includes steroid injections, lasers, and chemical peels, is projected to exhibit the highest growth rate of approximately 5% during the forecast period 2024-2029. This accelerated growth is primarily driven by the increasing preference for minimally invasive procedures and the growing demand for immediate results in acne treatment. The segment is witnessing significant technological advancements in laser therapies and chemical peel formulations, making these treatments more effective and accessible to a broader patient population. Furthermore, the rising aesthetic consciousness among consumers, coupled with the increasing disposable income in developing regions, is fueling the adoption of these alternative treatment methods. The segment's growth is also supported by the expanding network of dermatology clinics and aesthetic centers offering specialized acne treatments.
Segment Analysis: By Route of Administration
Topical Segment in Acne Therapeutics Market
The topical segment dominates the global topical acne medication market, accounting for approximately 64% of the total market share in 2024. This significant market position is driven by the widespread preference for topical treatments among both healthcare providers and patients due to their ease of application and lower risk of systemic side effects. Topical acne treatments, available in various forms including creams, lotions, gels, face washes, and scrubs, offer targeted treatment directly at the site of acne formation. The segment's leadership is further strengthened by the extensive availability of over-the-counter topical products and the continuous introduction of innovative formulations by key market players. Additionally, the growing consumer preference for combination topical therapies, which often provide enhanced efficacy through multiple mechanisms of action, has contributed to the segment's dominant position. The segment is also experiencing the highest growth rate in the market, projected to grow at approximately 5% from 2024 to 2029, driven by increasing research and development in novel delivery systems and the rising demand for prescription-strength topical treatments.
Oral Segment in Acne Therapeutics Market
The oral segment represents a crucial component of the oral acne medications market, offering systemic treatment options for moderate to severe acne cases. This segment encompasses various therapeutic options, including antibiotics, hormonal agents, and retinoids, which are particularly effective for patients who have not responded adequately to topical treatments alone. The segment's growth is supported by the increasing adoption of combination therapy approaches, where oral medications are prescribed alongside topical treatments for enhanced therapeutic outcomes. Healthcare providers often prescribe oral medications for patients with inflammatory acne, nodular acne, or cases where topical treatments alone prove insufficient. The segment's expansion is also driven by ongoing advancements in oral drug formulations that aim to minimize side effects while maximizing therapeutic benefits. The development of novel oral treatments with improved safety profiles and patient compliance features continues to strengthen this segment's position in the overall acne treatment drug market.
Acne Therapeutics Market Geography Segment Analysis
Acne Therapeutics Market in North America
North America represents a dominant force in the global acne market, characterized by advanced healthcare infrastructure and high awareness levels about skin health. The region's market is primarily driven by the United States, Canada, and Mexico, with factors such as increasing healthcare expenditure, rising adoption of innovative treatment options, and growing awareness about skincare contributing to market growth. The presence of major pharmaceutical companies and extensive research and development activities further strengthens the region's market position.

Acne Therapeutics Market in the United States
The United States leads the North American market with approximately 87% acne treatment market share in 2024. The country's dominance is attributed to its robust healthcare system, high healthcare spending per capita, and strong presence of key market players. The market is further driven by factors such as the increasing prevalence of acne among both adolescents and adults, with studies indicating that acne affects about 50 million Americans annually. The country's advanced healthcare infrastructure, coupled with favorable reimbursement policies and increasing adoption of innovative acne treatments, continues to strengthen its market position.
Acne Therapeutics Market in Canada
Canada emerges as the fastest-growing market in North America, with an expected growth rate of approximately 5% during 2024-2029. The growth is primarily driven by increasing awareness about acne treatment options and rising healthcare expenditure. The Canadian market benefits from its universal healthcare system and growing focus on dermatological care, with about 5.6 million people affected by acne in the country. The market is further supported by increasing research and development activities, growing adoption of advanced therapeutic solutions, and a rising number of product launches by key market players.
Acne Therapeutics Market in Europe
Europe represents a significant market for acne therapeutics, with a well-established healthcare infrastructure and growing focus on dermatological care. The region's market is characterized by the presence of key countries including Germany, the United Kingdom, France, Italy, and Spain. The Europe acne treatment market benefits from increasing research and development activities, rising adoption of advanced treatment options, and growing awareness about skin health among the population. The presence of major pharmaceutical companies and research institutions further strengthens the region's market position.
Acne Therapeutics Market in Germany
Germany maintains its position as the largest market in Europe, holding approximately 23% market share in 2024. The country's market leadership is supported by its advanced healthcare system, high healthcare expenditure, and strong presence of pharmaceutical companies. The German market is characterized by high adoption rates of innovative acne treatments, extensive research and development activities, and growing awareness about skin health among the population. The country's robust healthcare infrastructure and favorable reimbursement policies continue to drive market growth.
Acne Therapeutics Market in France
France demonstrates the highest growth potential in the European region, with an expected growth rate of approximately 5% during 2024-2029. The French market is driven by increasing awareness about acne treatments, rising healthcare expenditure, and growing adoption of advanced therapeutic solutions. The country's strong focus on dermatological research, coupled with the presence of major pharmaceutical companies and research institutions, supports market growth. The market also benefits from increasing product launches and rising demand for innovative acne treatments.
Acne Therapeutics Market in Asia-Pacific
The Asia-Pacific acne treatment market represents a rapidly evolving market for acne therapeutics, characterized by increasing healthcare expenditure, growing awareness about skin health, and rising adoption of advanced treatment options. The region encompasses key markets including China, Japan, India, Australia, and South Korea. The market is driven by factors such as a large patient population, improving healthcare infrastructure, and increasing disposable income levels across major economies.
Acne Therapeutics Market in China
China maintains its position as the largest market in the Asia-Pacific region, driven by its vast population base and increasing healthcare expenditure. The Chinese market benefits from improving healthcare infrastructure, rising awareness about skin health, and growing adoption of advanced acne treatments. The country's market is further strengthened by increasing research and development activities, a rising number of product launches, and the growing presence of both domestic and international pharmaceutical companies.
Acne Therapeutics Market in India
India emerges as the fastest-growing market in the Asia-Pacific region, driven by factors such as increasing awareness about acne treatments, improving healthcare infrastructure, and rising disposable income levels. The Indian market benefits from a large patient population, growing adoption of advanced therapeutic solutions, and an increasing presence of pharmaceutical companies. The market is further supported by rising research and development activities and a growing focus on dermatological care.
Acne Therapeutics Market in Middle East & Africa
The Middle East & Africa region presents a growing market for acne therapeutics, with GCC countries and South Africa serving as key markets. The region's market is characterized by improving healthcare infrastructure, increasing awareness about skin health, and rising adoption of advanced treatment options. Among the countries, GCC emerges as the largest market while South Africa demonstrates the fastest growth potential, driven by factors such as increasing healthcare expenditure and a growing focus on dermatological care.
Acne Therapeutics Market in South America
South America represents an emerging market for acne therapeutics, with Brazil and Argentina serving as key contributors to market growth. The region's market is driven by factors such as improving healthcare infrastructure, increasing awareness about skin health, and rising adoption of advanced treatment options. Brazil emerges as both the largest and fastest-growing market in the region, supported by factors such as a large patient population, increasing healthcare expenditure, and a growing presence of pharmaceutical companies.
Acne Therapeutics Industry Overview
Top Companies in Acne Therapeutics Market
The acne therapeutics market features prominent players like Johnson & Johnson, L'Oréal, GlaxoSmithKline, Bausch Health, Sun Pharmaceuticals, and AbbVie, who are driving innovation through extensive R&D investments. Companies are focusing on developing novel drug delivery systems, particularly in topical applications, while expanding their product portfolios through strategic licensing agreements and partnerships. The industry demonstrates strong operational agility through rapid adaptation to changing market demands, especially in response to growing consumer preference for natural and organic solutions. Market leaders are strengthening their positions through geographic expansion, particularly in emerging markets, while simultaneously investing in advanced research facilities and manufacturing capabilities. Strategic moves increasingly emphasize digital transformation, with companies incorporating AI and machine learning for product development and patient engagement, alongside establishing direct-to-consumer channels and telemedicine partnerships.
Consolidated Market Led By Global Players
The acne therapeutics market exhibits a moderately consolidated structure dominated by multinational pharmaceutical conglomerates with diverse product portfolios spanning multiple therapeutic areas. These industry leaders leverage their extensive research capabilities, global distribution networks, and strong brand recognition to maintain market leadership. The landscape is characterized by a mix of pure-play dermatology specialists and diversified healthcare companies, with regional players maintaining strong positions in specific geographic markets through localized product offerings and distribution partnerships.
The market has witnessed significant merger and acquisition activity, particularly focused on acquiring innovative startups and biotechnology companies with promising pipeline products. Large pharmaceutical companies are increasingly pursuing strategic acquisitions to expand their dermatology portfolios and gain access to novel drug delivery technologies. This consolidation trend is particularly evident in developed markets, where companies are seeking to strengthen their market presence through vertical integration and portfolio diversification, while simultaneously establishing partnerships with local players in emerging markets to enhance market penetration.
Innovation and Market Access Drive Success
Success in the acne treatment market increasingly depends on companies' ability to develop differentiated products that address unmet patient needs while navigating complex regulatory requirements. Incumbent players are focusing on expanding their product portfolios through internal R&D and strategic collaborations, while simultaneously strengthening their distribution networks and patient engagement platforms. Market leaders are investing in real-world evidence generation and patient outcome studies to demonstrate product efficacy and value proposition, while also developing innovative pricing strategies to enhance market access and patient affordability.
New entrants and challenger brands are gaining ground by focusing on niche market segments and developing specialized products for specific patient populations. Companies are increasingly leveraging digital technologies and direct-to-consumer marketing strategies to build brand awareness and patient relationships. The market demonstrates moderate substitution risk from alternative treatments and natural remedies, necessitating continuous innovation and product differentiation. Success factors also include the ability to navigate evolving regulatory requirements, particularly regarding safety documentation and clinical evidence, while maintaining strong relationships with healthcare providers and payers to ensure market access and reimbursement coverage.
Acne Therapeutics Market Leaders
-
Teva Pharmaceuticals
-
L'Oréal S.A. (La Roche-Posay Laboratoire Dermatologique)
-
Sun Pharmaceutical Industries, Inc.
-
JOHNSON & JOHNSON
-
Abbvie Inc (Allergan PLC)
- *Disclaimer: Major Players sorted in no particular order

Acne Therapeutics Market News
- February 2024: DTC hair health brand Nutrafol launched Nutrafol Skin, a daily supplement aimed at targeting acne.
- December 2023: Sun Pharma Canada Inc. launched the PRABSORICA LD (isotretinoin capsules) in Canada. ABSORICA LD is a new formulation of isotretinoin used to treat severe nodular and/or inflammatory acne, acne conglobata, and recalcitrant acne in patients 12 years of age and older.
Acne Therapeutics Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Sedentary Lifestyles and Unhealthy Food Habits
- 4.2.2 Increasing Awareness About Current and Upcoming Acne Treatments
- 4.2.3 High Global Acne Prevalence
-
4.3 Market Restraints
- 4.3.1 Safety Issues Regarding the Products
- 4.3.2 Entry of Generics in the Market
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Treatment
- 5.1.1 Therapeutics
- 5.1.1.1 Retinoid
- 5.1.1.2 Antibiotics
- 5.1.1.3 Hormonal Agents
- 5.1.1.4 Anti-inflammatory
- 5.1.1.5 Other Therapeutics
- 5.1.2 Other Treatments
-
5.2 By Route of Administration
- 5.2.1 Oral
- 5.2.2 Topical
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Cipher Pharmaceuticals
- 6.1.2 GlaxoSmithKline PLC
- 6.1.3 L'Oréal SA (La Roche-Posay Laboratoire Dermatologique)
- 6.1.4 Teva Pharmaceuticals
- 6.1.5 Sun Pharmaceuticals (Ranbaxy)
- 6.1.6 Abbvie Inc (Allergan PLC)
- 6.1.7 F. Hoffmann-la Roche Ltd
- 6.1.8 Viatris Inc. (MYLAN)
- 6.1.9 Johnson & Johnson
- 6.1.10 Bausch Health Companies Inc.
- 6.1.11 Galderma SA
- 6.1.12 Journey Medical Corporation
- 6.1.13 Boston Pharmaceuticals Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Acne Therapeutics Industry Segmentation
As per the scope of the report, acne is a chronic inflammatory skin disease commonly affecting adolescent and adult populations. Abnormal hormone production is found to be the key causative factor. Acne therapeutics include several prescriptions and over-the-counter medicines, such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives.
The acne therapeutics market is segmented by treatment, route of administration, and geography. The treatment segment is differentiated into therapeutics and other treatments. The route of administration is segmented into oral and topical. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD) for the above segments.
By Treatment | Therapeutics | Retinoid | |
Antibiotics | |||
Hormonal Agents | |||
Anti-inflammatory | |||
Other Therapeutics | |||
Other Treatments | |||
By Route of Administration | Oral | ||
Topical | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Acne Therapeutics Market Research FAQs
How big is the Acne Therapeutics Market?
The Acne Therapeutics Market size is expected to reach USD 9.06 billion in 2025 and grow at a CAGR of 4.89% to reach USD 11.51 billion by 2030.
What is the current Acne Therapeutics Market size?
In 2025, the Acne Therapeutics Market size is expected to reach USD 9.06 billion.
Who are the key players in Acne Therapeutics Market?
Teva Pharmaceuticals, L'Oréal S.A. (La Roche-Posay Laboratoire Dermatologique), Sun Pharmaceutical Industries, Inc., JOHNSON & JOHNSON and Abbvie Inc (Allergan PLC) are the major companies operating in the Acne Therapeutics Market.
Which is the fastest growing region in Acne Therapeutics Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Acne Therapeutics Market?
In 2025, the North America accounts for the largest market share in Acne Therapeutics Market.
What years does this Acne Therapeutics Market cover, and what was the market size in 2024?
In 2024, the Acne Therapeutics Market size was estimated at USD 8.62 billion. The report covers the Acne Therapeutics Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Acne Therapeutics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Acne Therapeutics Market Research
Mordor Intelligence provides a comprehensive analysis of the acne therapeutics market. We leverage our extensive experience in healthcare market research and consulting. Our latest report examines the full range of acne vulgaris treatments. This includes a detailed analysis of both topical acne medications and oral acne medicine segments. The study offers in-depth coverage of acne treatment market trends across key regions such as the Europe acne treatment market, Asia Pacific, and the Americas, with a particular focus on cystic acne management solutions.
The report gives stakeholders crucial insights into acne treatment market growth dynamics. It is supported by extensive data on acne prevalence by country and regional market developments. Our analysis covers various therapeutic approaches, from topical androgen receptor inhibitors to advanced retinoid treatment for skin conditions. This provides valuable intelligence for pharmaceutical companies, healthcare providers, and investors. The report, available in an easy-to-download PDF format, includes a detailed examination of drug types in the acne treatment market, route of administration patterns, and emerging therapeutic solutions. This enables stakeholders to make informed strategic decisions in this evolving market landscape.